| Source NDC Code |
|
Target HCPCS Code |
00069-4494-01
ELREXFIO 4
|
⇄
|
C9165
Injection, elranatamab-bcmm, 1 mg
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
0 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
00069-4494-01
ELREXFIO 76 MG/1.9 ML VIAL
|
⇄
|
J1323
Injection, elranatamab-bcmm, 1 mg
|
| Detail Information |
| Relationship Start Date |
04/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.9 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
00069-4494-01
ELREXFIO 4
|
⇄
|
J9999
Not Otherwise Classified, Antineoplastic Drugs
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
03/31/2024 |
| Number Of Items In Ndc Package |
0 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|